Getinge Industrier AB (GNGBY)
Getinge Industrier AB is listed on OTC Markets in the form of an ADR representing the common stock of Getinge AB (publ). The underlying issuer develops products and solutions for operating rooms, intensive care units, and sterilization departments in Sweden and international markets. Its activities are organized across Acute Care Therapies, Life Science, and Surgical Workflows. The company’s portfolio includes extracorporeal membrane oxygenation, mechanical ventilation, patient monitoring, ICU infrastructure equipment, drainage solutions, surgical perfusion, endoscopic vessel harvesting, vascular and cardiothoracic surgery equipment, operating room integration systems, anesthesia solutions, and sterilization and reprocessing technologies. It also supplies connected medical devices, patient flow management tools, and bioprocess and laboratory sterilization solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-GNGB.Y
|
$26.98
|
12.9% Upside
|
Fair
|
—
|
—
|
—
|
Great
|
—
|
—
|
0.36
|
1.5%
|
October 20, 2026
|
23.5x
|
2.0x
|
1.8x
|
6.532 B
|
7.422 B
|
15.1%
|
65.5%
|
10.3
|
48.8%
|
142.2%
|
